Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SZ1108 tablets in type 2 diabetes-related chronic kidney disease
CTR20260110Phase 2Active
- Sponsor
- Suzhong Pharmaceutical Group Co., Ltd.
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SZ1108 in diabetic glomerulosclerosis, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), sponsored by Suzhong Pharmaceutical Group Co., Ltd.. Started Mar 2026; status: active.
02
Drugs
SZ1108
03
Conditions
diabetic glomerulosclerosischronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20260110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260110.